Faculty

Needs Statement

Vaccine hesitancy is a major issue that primary care physicians, nurses, and pharmacists currently face. This enduring module would teach the healthcare team how to combat vaccine hesitancy issues head-on by discerning personality types, addressing fears, and dispelling myths about the COVID-19 vaccine. 

Target Audience

The target audience of this course includes physicians, advanced practice providers, pharmacists, nurses, and other clinicians that need to dispel myths about the virus and the vaccine.

Objectives

Upon completion of this activity, participants will be able to:

1. Frame discussions about the severity and susceptibility to COVID-19
2. Provide information to patients about the three vaccines (their utilization, side effects, and the manufacturing process)
3. Dispel misinformation regarding the three available vaccines
4. Discuss expenses for patients who are cost-aware.
5. Identify the perceived barriers that patients encounter when accessing the COVID-19 vaccine

Accreditation

In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME
This enduring material is designated for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

IPE Competencies

• Roles/ Responsibilities

CPE
This knowledge-based activity will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. 

No speakers, authors, planners, or content reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgment

This activity is supported by an independent educational grant from WellCare Health Plans, Inc.